Connect with us

Hi, what are you looking for?

Jewish Business News

Money

Ceragon Networks raising $31.4 Million in Nasdaq Offering of Ordinary Shares

The company will issue 14 million shares at $2.40 per share, a ten-year low.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.

ira_palati_PR

CEO Ira Palati

Ceragon Networks Ltd. (NASDAQ: CRNT), today announced the pricing of an underwritten public offering of 14, 000, 000 of its ordinary shares at a price of $2.40 per share. The company has also granted to the underwriters a 30-day option to acquire an additional 1, 600, 000 shares to cover overallotments in connection with the offering. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $31.4 million, assuming no exercise of the overallotment option. The offering is expected to close on November 26, 2013, subject to customary closing conditions.

Needham & Company is acting as lead book-running manager of the offering. Oppenheimer & Co. is acting as co-book runner.

Ceragon intends to use the net proceeds from the offering for general corporate purposes. The shares described above are being offered by Ceragon pursuant to a registration statement on Form F-3, including a base prospectus, previously filed with and subsequently declared effective by the Securities and Exchange Commission. The securities may be offered only by means of a prospectus. A preliminary prospectus supplement relating to the offering was filed with the SEC on November 19, 2013 and a final prospectus supplement relating to the offering will be filed with the SEC.

 

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Life-Style Health

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...